Bridgewater Associates »

BioCryst Pharmaceuticals shares owned by Bridgewater Associates

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Bridgewater Associates from 13F filings

Historical chart of Bridgewater Associates investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Bridgewater Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Bridgewater Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1M 412k 7.59

More positions owned by Bridgewater Associates

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
salesforce (CRM)
NVIDIA Corporation (NVDA)
Lam Research Corp Com New (LRCX)
Adobe Systems Incorporated (ADBE)
Booking Holdings (BKNG)
Ge Vernova (GEV)
Uber Technologies (UBER)
Johnson & Johnson (JNJ)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Sea Sponsord Ads (SE)

View all positions for Bridgewater Associates

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals